Buy Or Sell Opportunity • Jun 24
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 24% to ₹2,014. The fair value is estimated to be ₹1,656, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.9% over the last 3 years. Earnings per share has declined by 9.3%. Revenue is forecast to grow by 17% in 2 years. Earnings are forecast to grow by 33% in the next 2 years. Board Change • Jun 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Sangeeta Jit Singh was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • May 16
Full year 2026 earnings: EPS misses analyst expectations Full year 2026 results: EPS: ₹75.41 (down from ₹86.00 in FY 2025). Revenue: ₹52.7b (up 25% from FY 2025). Net income: ₹2.67b (down 12% from FY 2025). Profit margin: 5.1% (down from 7.2% in FY 2025). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 8.2%. Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 11% per year. Announcement • May 15
Galaxy Surfactants Limited, Annual General Meeting, Aug 12, 2026 Galaxy Surfactants Limited, Annual General Meeting, Aug 12, 2026. Announcement • May 07
Galaxy Surfactants Limited to Report Q4, 2026 Results on May 14, 2026 Galaxy Surfactants Limited announced that they will report Q4, 2026 results on May 14, 2026 Buy Or Sell Opportunity • Mar 25
Now 22% overvalued Over the last 90 days, the stock has fallen 22% to ₹1,623. The fair value is estimated to be ₹1,333, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.8% over the last 3 years. Earnings per share has declined by 10.0%. For the next 3 years, revenue is forecast to grow by 6.8% per annum. Earnings are also forecast to grow by 13% per annum over the same time period. Reported Earnings • Feb 16
Third quarter 2026 earnings: EPS and revenues exceed analyst expectations Third quarter 2026 results: EPS: ₹16.63 (down from ₹18.22 in 3Q 2025). Revenue: ₹13.3b (up 28% from 3Q 2025). Net income: ₹589.7m (down 8.7% from 3Q 2025). Profit margin: 4.4% (down from 6.2% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 9.6%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 9% per year. Announcement • Feb 05
Galaxy Surfactants Limited to Report Q3, 2026 Results on Feb 13, 2026 Galaxy Surfactants Limited announced that they will report Q3, 2026 results at 12:08 PM, Indian Standard Time on Feb 13, 2026 Price Target Changed • Nov 16
Price target decreased by 7.6% to ₹2,486 Down from ₹2,692, the current price target is an average from 12 analysts. New target price is 16% above last closing price of ₹2,144. Stock is down 22% over the past year. The company is forecast to post earnings per share of ₹79.19 for next year compared to ₹86.00 last year. Reported Earnings • Nov 14
Second quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2026 results: EPS: ₹13.75 (down from ₹23.90 in 2Q 2025). Revenue: ₹13.3b (up 25% from 2Q 2025). Net income: ₹664.9m (down 22% from 2Q 2025). Profit margin: 5.0% (down from 8.0% in 2Q 2025). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.2%. Earnings per share (EPS) missed analyst estimates by 18%. Revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 10% per year. Announcement • Nov 05
Galaxy Surfactants Limited to Report Q2, 2026 Results on Nov 12, 2025 Galaxy Surfactants Limited announced that they will report Q2, 2026 results on Nov 12, 2025 Reported Earnings • Jul 23
Full year 2025 earnings: EPS and revenues exceed analyst expectations Full year 2025 results: EPS: ₹86.00 (up from ₹85.03 in FY 2024). Revenue: ₹42.2b (up 11% from FY 2024). Net income: ₹3.05b (up 1.1% from FY 2024). Profit margin: 7.2% (down from 7.9% in FY 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) also surpassed analyst estimates by 2.8%. Revenue is forecast to grow 8.1% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 5% per year. Declared Dividend • Jul 17
Final dividend of ₹4.00 announced Shareholders will receive a dividend of ₹4.00. Ex-date: 1st August 2025 Payment date: 11th September 2025 Dividend yield will be 0.8%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (33% cash payout ratio). The dividend has increased by an average of 18% per year over the past 7 years. However, payments have been volatile during that time. EPS is expected to grow by 35% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Announcement • May 19
Galaxy Surfactants Limited, Annual General Meeting, Aug 12, 2025 Galaxy Surfactants Limited, Annual General Meeting, Aug 12, 2025. Reported Earnings • May 17
Full year 2025 earnings: EPS and revenues exceed analyst expectations Full year 2025 results: EPS: ₹86.00 (up from ₹85.03 in FY 2024). Revenue: ₹42.5b (up 12% from FY 2024). Net income: ₹3.05b (up 1.1% from FY 2024). Profit margin: 7.2% (down from 7.9% in FY 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) also surpassed analyst estimates by 2.8%. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 8% per year, which means it is performing significantly worse than earnings. Announcement • May 10
Galaxy Surfactants Limited to Report Q4, 2025 Results on May 16, 2025 Galaxy Surfactants Limited announced that they will report Q4, 2025 results on May 16, 2025 Announcement • Mar 15
Galaxy Surfactants Limited Approves Interim Dividend for the Year 2024-25 Galaxy Surfactants Limited announced that at its board meeting held on March 15, 2025, the board approved the Interim Dividend of INR 18/- per equity share having face value of INR 10/- each for the financial year 2024-25. The record date for payment of this interim dividend is fixed as March 20, 2025. The interim dividend shall be paid within 30 days from the date of its declaration to the shareholders whose name appears in the Register of Members as on the record date. Price Target Changed • Feb 13
Price target decreased by 7.4% to ₹2,979 Down from ₹3,216, the current price target is an average from 11 analysts. New target price is 29% above last closing price of ₹2,316. Stock is down 8.5% over the past year. The company is forecast to post earnings per share of ₹83.02 for next year compared to ₹85.03 last year. Reported Earnings • Feb 11
Third quarter 2025 earnings: EPS misses analyst expectations Third quarter 2025 results: EPS: ₹18.22 (down from ₹20.13 in 3Q 2024). Revenue: ₹10.4b (up 11% from 3Q 2024). Net income: ₹646.1m (down 9.5% from 3Q 2024). Profit margin: 6.2% (down from 7.6% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 25%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Announcement • Feb 03
Galaxy Surfactants Limited to Report Q3, 2025 Results on Feb 10, 2025 Galaxy Surfactants Limited announced that they will report Q3, 2025 results on Feb 10, 2025 Reported Earnings • Nov 12
Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2025 results: EPS: ₹23.90 (up from ₹21.84 in 2Q 2024). Revenue: ₹10.7b (up 9.0% from 2Q 2024). Net income: ₹847.1m (up 9.4% from 2Q 2024). Profit margin: 7.9% (in line with 2Q 2024). Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 3.2%. Revenue is forecast to grow 10.0% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Announcement • Nov 05
Galaxy Surfactants Limited to Report Q2, 2025 Results on Nov 11, 2024 Galaxy Surfactants Limited announced that they will report Q2, 2025 results on Nov 11, 2024 Announcement • Aug 13
Galaxy Surfactants Limited Announces Change in Directorate Galaxy Surfactants Limited informed that Mr. M.G. Parmeswaran (DIN: 00792123) and Mr. Subodh Nadkarni (DIN: 00145999) completed their second term as Independent Directors on August 12, 2024. Date of cessation effective August 13, 2024. Announcement • Aug 02
Galaxy Surfactants Limited to Report Q1, 2025 Results on Aug 08, 2024 Galaxy Surfactants Limited announced that they will report Q1, 2025 results on Aug 08, 2024 Reported Earnings • Jul 13
Full year 2024 earnings: Revenues and EPS in line with analyst expectations Full year 2024 results: EPS: ₹85.03 (down from ₹107 in FY 2023). Revenue: ₹37.9b (down 15% from FY 2023). Net income: ₹3.01b (down 21% from FY 2023). Profit margin: 7.9% (down from 8.5% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 8.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Declared Dividend • Jul 12
Dividend of ₹22.00 announced Shareholders will receive a dividend of ₹22.00. Ex-date: 26th July 2024 Payment date: 6th September 2024 Dividend yield will be 0.7%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 21% per year over the past 6 years. However, payments have been volatile during that time. EPS is expected to grow by 51% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Announcement • May 24
Galaxy Surfactants Limited, Annual General Meeting, Aug 07, 2024 Galaxy Surfactants Limited, Annual General Meeting, Aug 07, 2024. Reported Earnings • May 22
Full year 2024 earnings: Revenues and EPS in line with analyst expectations Full year 2024 results: EPS: ₹85.03 (down from ₹107 in FY 2023). Revenue: ₹38.3b (down 14% from FY 2023). Net income: ₹3.01b (down 21% from FY 2023). Profit margin: 7.9% (down from 8.6% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Announcement • May 16
Galaxy Surfactants Limited to Report Q4, 2024 Results on May 21, 2024 Galaxy Surfactants Limited announced that they will report Q4, 2024 results on May 21, 2024 Reported Earnings • Feb 13
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: EPS: ₹20.13 (down from ₹29.96 in 3Q 2023). Revenue: ₹9.47b (down 12% from 3Q 2023). Net income: ₹713.7m (down 33% from 3Q 2023). Profit margin: 7.5% (down from 9.8% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 6% per year. Announcement • Feb 06
Galaxy Surfactants Limited to Report Q3, 2024 Results on Feb 12, 2024 Galaxy Surfactants Limited announced that they will report Q3, 2024 results at 4:00 PM, Indian Standard Time on Feb 12, 2024 Buy Or Sell Opportunity • Feb 05
Now 20% overvalued Over the last 90 days, the stock has fallen 6.9% to ₹2,634. The fair value is estimated to be ₹2,195, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 11%. For the next 3 years, revenue is forecast to grow by 7.7% per annum. Earnings are also forecast to grow by 12% per annum over the same time period. Reported Earnings • Nov 15
Second quarter 2024 earnings released: EPS: ₹21.84 (vs ₹23.65 in 2Q 2023) Second quarter 2024 results: EPS: ₹21.84 (down from ₹23.65 in 2Q 2023). Revenue: ₹9.83b (down 20% from 2Q 2023). Net income: ₹774.2m (down 7.7% from 2Q 2023). Profit margin: 7.9% (up from 6.8% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 13% per year. Announcement • Nov 12
Galaxy Surfactants Limited Re-Designates Vaijanath Kulkarni as Executive Director & Chief Operating Officer, Effective from February 18, 2024 Galaxy Surfactants Limited announced Mr. Vaijanath Kulkarni, Whole-time Director (DIN: 07626842) will re-designated as Executive Director & Chief Operating Officer with effect from February 18, 2024. Announcement • Nov 04
Galaxy Surfactants Limited to Report Q2, 2024 Results on Nov 10, 2023 Galaxy Surfactants Limited announced that they will report Q2, 2024 results on Nov 10, 2023 Announcement • Aug 05
Galaxy Surfactants Limited to Report Q1, 2024 Results on Aug 11, 2023 Galaxy Surfactants Limited announced that they will report Q1, 2024 results on Aug 11, 2023 Upcoming Dividend • Jul 21
Upcoming dividend of ₹4.00 per share at 0.8% yield Eligible shareholders must have bought the stock before 28 July 2023. Payment date: 09 September 2023. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 0.8%. Lower than top quartile of Indian dividend payers (1.5%). In line with average of industry peers (0.9%). Reported Earnings • Jul 18
Full year 2023 earnings: EPS and revenues exceed analyst expectations Full year 2023 results: EPS: ₹107 (up from ₹74.12 in FY 2022). Revenue: ₹44.5b (up 21% from FY 2022). Net income: ₹3.81b (up 45% from FY 2022). Profit margin: 8.6% (up from 7.1% in FY 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 2.7%. Revenue is forecast to stay flat during the next 3 years compared to a 10.0% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 18% per year. Announcement • May 25
Galaxy Surfactants Limited, Annual General Meeting, Aug 10, 2023 Galaxy Surfactants Limited, Annual General Meeting, Aug 10, 2023. Announcement • May 24
Galaxy Surfactants Limited Recommends Final Dividend for Financial Year 2022-2023 Galaxy Surfactants Limited announced that at its board meeting held on May 23, 2023, recommended final dividend of INR 4.00 per equity share of face value of INR 10 each for Financial year 2022-2023. Reported Earnings • May 24
Full year 2023 earnings: EPS and revenues exceed analyst expectations Full year 2023 results: EPS: ₹107 (up from ₹74.12 in FY 2022). Revenue: ₹44.6b (up 21% from FY 2022). Net income: ₹3.81b (up 45% from FY 2022). Profit margin: 8.6% (up from 7.1% in FY 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 2.7%. Revenue is forecast to stay flat during the next 2 years compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Feb 12
Third quarter 2023 earnings released: EPS: ₹29.96 (vs ₹12.86 in 3Q 2022) Third quarter 2023 results: EPS: ₹29.96 (up from ₹12.86 in 3Q 2022). Revenue: ₹10.8b (up 16% from 3Q 2022). Net income: ₹1.06b (up 133% from 3Q 2022). Profit margin: 9.8% (up from 4.9% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 1.3% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 12% per year. Announcement • Feb 12
Galaxy Surfactants Limited Declares Interim Dividend Galaxy Surfactants Limited announced that at its board meeting held on February 11, 2023, declared an interim dividend of INR 18 per equity share of face value of INR 10 each. As informed earlier the record date for the payment of interim dividend will be February 20, 2023. Announcement • Feb 05
Galaxy Surfactants Limited to Report Q3, 2023 Results on Feb 11, 2023 Galaxy Surfactants Limited announced that they will report Q3, 2023 results on Feb 11, 2023 Major Estimate Revision • Nov 16
Consensus revenue estimates increase by 12% The consensus outlook for revenues in 2023 has improved. 2023 revenue forecast increased from ₹40.5b to ₹45.4b. EPS estimate increased from ₹91.05 to ₹94.70 per share. Net income forecast to grow 2.9% next year vs 21% growth forecast for Chemicals industry in India. Consensus price target down from ₹3,432 to ₹3,325. Share price rose 3.0% to ₹2,889 over the past week. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Independent Director Kanwar Bir Anand was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Oct 09
Galaxy Surfactants Limited Announces Cessation of K Ganesh Kamath as Executive Director Galaxy Surfactants Limited announced that Mr. K Ganesh Kamath has completed his term as an Executive Director on attaining superannuation on October 6, 2022. Further he has also decided to step down as a director by rotation from the Board of the Company with effect from October 7, 2022. Price Target Changed • Aug 12
Price target increased to ₹3,492 Up from ₹3,205, the current price target is an average from 7 analysts. New target price is 9.3% above last closing price of ₹3,196. Stock is up 4.7% over the past year. The company is forecast to post earnings per share of ₹93.20 for next year compared to ₹74.12 last year. Announcement • Aug 03
Galaxy Surfactants Limited to Report Q1, 2023 Results on Aug 09, 2022 Galaxy Surfactants Limited announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 09, 2022 Upcoming Dividend • Jul 14
Upcoming dividend of ₹18.00 per share Eligible shareholders must have bought the stock before 21 July 2022. Payment date: 04 September 2022. Payout ratio is a comfortable 24% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.8%). Lower than average of industry peers (0.8%). Reported Earnings • Jul 13
Full year 2022 earnings: EPS exceeds analyst expectations Full year 2022 results: EPS: ₹74.12 (down from ₹85.22 in FY 2021). Revenue: ₹36.9b (up 32% from FY 2021). Net income: ₹2.63b (down 13% from FY 2021). Profit margin: 7.1% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 19%. Over the next year, revenue is forecast to grow 5.1%, compared to a 17% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • May 19
Full year 2022 earnings: EPS exceeds analyst expectations Full year 2022 results: EPS: ₹74.12 (down from ₹85.22 in FY 2021). Revenue: ₹36.9b (up 32% from FY 2021). Net income: ₹2.63b (down 13% from FY 2021). Profit margin: 7.1% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 19%. Over the next year, revenue is forecast to grow 4.0%, compared to a 21% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 3 highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Nandita Gurjar was the last independent director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Apr 21
Galaxy Surfactants Limited Announces Management Appointments Galaxy Surfactants Limited announced at its board meeting held on April 19, 2022 appointed Mr. M. G. Parameswaran Independent Director as Chairman of the Board and Mr. M.G. Parameswaran as Chairman of the Board, Mrs. Nandita Gurjar Independent Director has been appointed as the Chairperson of Nomination and Remuneration Committee. Mr. M.G. Parameswaran shall continue as a member of the said committee. Major Estimate Revision • Feb 19
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₹34.1b to ₹36.8b. EPS estimate fell from ₹71.51 to ₹62.81 per share. Net income forecast to grow 19% next year vs 22% growth forecast for Chemicals industry in India. Consensus price target down from ₹3,321 to ₹3,244. Share price was steady at ₹2,949 over the past week. Reported Earnings • Feb 15
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Third quarter 2022 results: EPS: ₹12.86 (down from ₹24.04 in 3Q 2021). Revenue: ₹9.29b (up 38% from 3Q 2021). Net income: ₹456.2m (down 47% from 3Q 2021). Profit margin: 4.9% (down from 13% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.6%. Earnings per share (EPS) also surpassed analyst estimates by 14%. Over the next year, revenue is forecast to grow 3.5%, compared to a 20% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Feb 03
Galaxy Surfactants Limited to Report Q3, 2022 Results on Feb 12, 2022 Galaxy Surfactants Limited announced that they will report Q3, 2022 results on Feb 12, 2022 Recent Insider Transactions • Dec 07
MD & Executive Director recently sold ₹1.2m worth of stock On the 1st of December, Unnathan Shekhar sold around 433 shares on-market at roughly ₹2,863 per share. This was the largest sale by an insider in the last 3 months. Unnathan has been a seller over the last 12 months, reducing personal holdings by ₹2.6m. Reported Earnings • Nov 11
Second quarter 2022 earnings released: EPS ₹11.83 (vs ₹23.06 in 2Q 2021) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹8.82b (up 23% from 2Q 2021). Net income: ₹419.4m (down 49% from 2Q 2021). Profit margin: 4.8% (down from 11% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth. Executive Departure • Sep 14
Non-Executive Director Uday Kamat has left the company On the 8th of September, Uday Kamat's tenure as Non-Executive Director ended after 3.4 years in the role. As of June 2021, Uday still personally held 33.00k shares (₹100m worth at the time). A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 4.92 years. Executive Departure • Sep 14
Non-Executive Director Gopalkrishnan Ramakrishnan has left the company On the 8th of September, Gopalkrishnan Ramakrishnan's tenure as Non-Executive Director ended after 11.9 years in the role. As of June 2021, Gopalkrishnan still personally held 4.22m shares (₹13b worth at the time). A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 4.92 years. Upcoming Dividend • Aug 24
Upcoming dividend of ₹4.00 per share Eligible shareholders must have bought the stock before 31 August 2021. Payment date: 08 October 2021. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.6%). In line with average of industry peers (0.7%). Reported Earnings • Aug 11
First quarter 2022 earnings released: EPS ₹21.67 (vs ₹15.93 in 1Q 2021) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2022 results: Revenue: ₹8.26b (up 36% from 1Q 2021). Net income: ₹768.2m (up 36% from 1Q 2021). Profit margin: 9.3% (in line with 1Q 2021). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Jun 11
Full year 2021 earnings released: EPS ₹85.22 (vs ₹64.99 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹27.8b (up 7.2% from FY 2020). Net income: ₹3.02b (up 31% from FY 2020). Profit margin: 11% (up from 8.9% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • May 22
Price target increased to ₹2,366 Up from ₹2,160, the current price target is an average from 7 analysts. New target price is 23% below last closing price of ₹3,074. Stock is up 136% over the past year. Recent Insider Transactions • Mar 14
MD & Executive Director recently sold ₹1.8m worth of stock On the 9th of March, Unnathan Shekhar sold around 736 shares on-market at roughly ₹2,380 per share. This was the largest sale by an insider in the last 3 months. Unnathan has been a seller over the last 12 months, reducing personal holdings by ₹6.8m. Is New 90 Day High Low • Mar 01
New 90-day high: ₹2,326 The company is up 21% from its price of ₹1,917 on 01 December 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₹811 per share. Reported Earnings • Feb 14
Third quarter 2021 earnings released: EPS ₹24.04 (vs ₹13.54 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹6.75b (up 7.8% from 3Q 2020). Net income: ₹852.3m (up 78% from 3Q 2020). Profit margin: 13% (up from 7.7% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Analyst Estimate Surprise Post Earnings • Feb 14
Earnings beat expectations, revenue disappoints Revenue missed analyst estimates by 5.8%. Earnings per share (EPS) exceeded analyst estimates by 7.1%. Over the next year, revenue is forecast to grow 14%, compared to a 20% growth forecast for the Chemicals industry in India. Announcement • Feb 02
Galaxy Surfactants Limited to Report Q3, 2021 Results on Feb 08, 2021 Galaxy Surfactants Limited announced that they will report Q3, 2021 results on Feb 08, 2021 Recent Insider Transactions • Jan 21
COO & Executive Director recently bought ₹2.0m worth of stock On the 12th of January, Natarajan Krishnan bought around 869 shares on-market at roughly ₹2,300 per share. This was the largest purchase by an insider in the last 3 months. Natarajan has been a buyer over the last 12 months, purchasing a net total of ₹3.0m worth in shares. Recent Insider Transactions • Jan 06
MD & Executive Director recently sold ₹320k worth of stock On the 28th of December, Unnathan Shekhar sold around 234 shares on-market at roughly ₹1,367 per share. In the last 3 months, they made an even bigger sale worth ₹1.8m. Unnathan has been a seller over the last 12 months, reducing personal holdings by ₹5.9m. Is New 90 Day High Low • Jan 04
New 90-day high: ₹2,134 The company is up 14% from its price of ₹1,865 on 06 October 2020. The Indian market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₹528 per share. Recent Insider Transactions • Dec 17
MD & Executive Director recently sold ₹1.8m worth of stock On the 10th of December, Unnathan Shekhar sold around 924 shares on-market at roughly ₹1,910 per share. This was the largest sale by an insider in the last 3 months. Unnathan has been a seller over the last 12 months, reducing personal holdings by ₹6.9m. Is New 90 Day High Low • Dec 16
New 90-day high: ₹2,028 The company is up 4.0% from its price of ₹1,952 on 17 September 2020. The Indian market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₹530 per share. Is New 90 Day High Low • Nov 18
New 90-day high: ₹1,996 The company is up 8.0% from its price of ₹1,843 on 20 August 2020. The Indian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₹455 per share. Valuation Update With 7 Day Price Move • Nov 18
Market bids up stock over the past week After last week's 18% share price gain to ₹1,996, the stock is trading at a trailing P/E ratio of 28.4x, up from the previous P/E ratio of 24.1x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past year are 32%. Reported Earnings • Nov 14
Second quarter 2021 earnings released: EPS ₹23.06 The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹7.19b (up 11% from 2Q 2020). Net income: ₹817.4m (up 22% from 2Q 2020). Profit margin: 11% (up from 10% in 2Q 2020). The increase in margin was driven by higher revenue. Announcement • Nov 04
Galaxy Surfactants Limited to Report Q2, 2021 Results on Nov 11, 2020 Galaxy Surfactants Limited announced that they will report Q2, 2021 results on Nov 11, 2020 Recent Insider Transactions • Oct 18
MD & Executive Director recently sold ₹660k worth of stock On the 13th of October, Unnathan Shekhar sold around 367 shares on-market at roughly ₹1,799 per share. In the last 3 months, they made an even bigger sale worth ₹977k. Unnathan has been a seller over the last 12 months, reducing personal holdings by ₹5.1m. Announcement • Aug 04
Galaxy Surfactants Limited to Report Q1, 2021 Results on Aug 11, 2020 Galaxy Surfactants Limited announced that they will report Q1, 2021 results on Aug 11, 2020 Announcement • Jul 17
Galaxy Surfactants Limited Provides Update on Tarapur Plant Operations Galaxy Surfactants Limited announced that in continuation of earlier disclosure dated April 15, 2020 on the captioned subject, the company would like to inform that the Company has restarted operations at its units in Tarapur Location(including the location where the incident occurred) in a phased manner after receiving necessary permissions from the statutory authorities. Announcement • Jun 18
Galaxy Surfactants Limited to Report Q4, 2020 Results on Jun 25, 2020 Galaxy Surfactants Limited announced that they will report Q4, 2020 results on Jun 25, 2020